Use: Labeled Indications - Information concerning storageof product.. Delivers time and circumstances for which an answer or combination will preserve comprehensive potency. By way of example, some options may possibly require refrigeration immediately after reconstitution although saved at place temperature before planning.

Inside the pharmaceutical prescription information inquiry / distribution system As outlined by claim one, if the results of willpower would be that the inquiry material would not conform on the enter information and designated problems of the evaluation and payment establishment and the insurer, lookup and establish the pharmaceutical team that satisfies these Pharmaceutical prescription information inquiry / distribution procedure characterized by distribution to healthcare institutions.

このような情報システムの構成の一例を図３に示す。本情報システム例では、審査支払機関・保険者・保険医療機関・保険薬局のそれぞれに設置される通信手段をそなえた通常のパーソナルコンピューターのような、少なくとも、表示及び出力部・入力部・データ格納部、を備えた端末、及び情報照会・判定を行う中央システムとが、インターネットのような通信回線を介して接続される。当該中央システムは、演算部・表示及び出力部・入力部・データ格納部から構成され、演算時に参照するデータファイルの例が図５に示される。

As an alternative, notify the medical establishment, and persuade the professional medical establishment to reselect prescription articles, Pharmaceutical prescription information inquiry / distribution process characterized by comprising

) presented from the health care institution at time of inquiry and information acquired beforehand As well as in serious-time whether or not the specified problems in the insurance provider to whom the insured is affiliated and also the examination and payment Business in charge are pleased.

The pharmaceutical prescription information inquiry / distribution system according to claim one, wherein a series of inquiry histories produced via the method is dispersed to an assessment payment Corporation and an insurance provider.

have the possible of remaining abused, and that could produce perfectly remaining threats from Detrimental effects if taken incorrectly,

医療機関による医薬品の処方に際しては、被保険者（患者）が保健医療機関で医師の診察を受け、その診断結果をもとに医師が処方箋を発行、同処方箋に基づき保険薬局にて医薬品が調剤、提供される、という流れになっている。保険が適用される医薬品の費用請求については、被保険者による一部費用負担を除くと、医療機関・保険薬局などが、レセプトと呼ばれる診療報酬明細書に、診療、検査、投薬、手術など医療行為の内容を記入し、月ごとに審査支払機関に提出、医療費を請求する。審査は、社会保険診療報酬支払基金と都道府県支部、国民健康保険中央会と各都道府県の国民健康保険団体連合会にて実施され、かかった医療費をそのまま医療保険から支払う「出来高払い制」を採用されている。

It truly is made up of assumed health care cost points calculated for every injuries and symptom categorised In accordance with situation, drug price tag conventional of utilised drugs, insurance points, other knowledge required for examination of health care payment aspects, etc. Pharmaceutical prescription information inquiry and distribution technique.

Consequently, when retaining the fairness of getting health care solutions, the insured / insurance provider / examination / payment establishment has the opportunity to pick a drug which get more info is considered attractive through the viewpoint of usefulness, price tag, and so on. Is just not supplied adequate. For that reason, the situation from the current creation would be that the insured individual / insurance company or examination / payment institution hopes to prescribe the strongest prescription among the choices whilst sustaining the fairness of acquiring healthcare services in Japan's medical insurance policies procedure.

The prescription should be signed via the prescriber by his / her hand. His/her deal with and registration range actually needs to be well prepared in the situation of perilous and habits-forming medicines.

When a prescription advised medication is selected by a clinical establishment, the dealing with status / inventory standing at a nearby insurance policy pharmacy is confirmed and the result is notified.

 Consider therapy modification - info demonstrate that the required brokers may possibly interact with one another within a clinically-important method and patient-unique evaluation need to be done to find out no matter if the advantages of concomitant therapy outweigh the threats. Unique actions need to be taken in order to realize the advantages and/or limit toxicity of concomitant use. Stay away from combination - facts show that the desired brokers may possibly communicate with one another in the clinically-significant manner and the risk frequently outweighs any probable advantage. Concurrent use of these agents is normally considered contraindicated. Take a look at Interactions - Listing of assay interferences when related

図１は、本発明の医薬品処方情報照会・配信方法を活用したビジネスモデルの一例の概略を示す図面であり、図２は、当該ビジネスモデルをより具体的に示す図面であり、図３は、情報システム構成の一例を示す図面であり、図４は、情報照会・判定の一例を示すフローチャートであり、図５は、本発明の医薬品処方情報照会・配信のための情報システム内のデータファイルの一例を示す図面であり、図６は、当該情報システムと接続した医療機関の端末の入出力イメージの一例を示す図である。